William Joseph Hogan, MD, B Ch

Rajiv Gulati, MD PhD is Chair of the Division of Interventional Cardiology in the Department of Cardiovascular Medicine. He is a consultant cardiologist with a subspecialty interest in interventional cardiology.

Dr. Paul Friedman is Chair of the Department of Cardiovascular Medicine at Mayo Clinic, Rochester, MN. He is board certified in cardiovascular medicine and cardiac electrophysiology. His clinical interests include atrial fibrillation management including medications, remote monitoring, ablation and left atrial appendage closure; ventricular arrhythmia (PVCs, VT) management; medical and ablative management of SVTs; complex cardiac ablations of atrial and ventricular arrhythmias; stroke prevention; and cardiac device insertion, including leadless pacemakers, subcutaneous defibrillators, ICDs and resynchronization devices.

Jacob Orme, M.D., Ph.D., is a medical oncologist at Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota. Dr. Orme is a genitourinary medical oncologist and translational physician scientist who works in the clinic and the laboratory to make cancer care better for his patients. With an emphasis on advanced prostate cancer, Dr. Orme discovered the source and consequence of soluble PD-L1 in immunotherapy-resistant cancers as well as a novel biomarker "switch" in advanced highly-resistant prostate cancers. These discoveries have led to the development of multiple new therapeutics and clinical trials. Mayo Clinic is the #1 hospital in the nation, according to the U.S. News & World Report, and the Cancer Center continually ranks among the top hospitals in the U.S. for cancer. Mayo Clinic Comprehensive Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer center.